DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer

被引：0

作者：

A Drouillard

F Puleo

J B Bachet

S Ouazzani

A Calomme

P Demetter

G Verset

J L Van Laethem

R Maréchal

机构：

[1] University Hospital of Dijon,Department of Gastroenterology and Digestive Oncology

[2] Digestive Cancer Registry of Burgundy,Department of Gastroenterology and Digestive Oncology

[3] INSERM U866,Department of Hepatogastroenterology

[4] University Hospital of Dijon,Department of Pathology

[5] Erasme Hospital,undefined

[6] Pitié Salpêtrière Hospital,undefined

[7] APHP,undefined

[8] Erasme Hospital,undefined

[9] Laboratory of Experimental Gastroenterology,undefined

[10] Université Libre de Bruxelles,undefined

来源：

British Journal of Cancer | 2016年 / 115卷

关键词：

DLL4; Notch1; Notch3; pancreatic cancer; biomarker; immunohistochemistry;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1245 / 1252

页数：7

共 50 条

[1] DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
Drouillard, A.
Puleo, F.
Bachet, J. B.
Ouazzani, S.
Calomme, A.
Demetter, P.
Verset, G.
Van Laethem, J. L.
Marechal, R.
BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1245 - 1252
[2] Prognostic significance of DLL4 expression in papillary thyroid cancer
Zhang, Y. -Z.
Qin, F.
Han, Z. -G.
Liu, Q.
Zhou, L.
Wang, Y. -W.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (15) : 2901 - 2905
[3] Clinical implications of DLL4 expression in gastric cancer
Sumiya Ishigami
Takaaki Arigami
Yoshikazu Uenosono
Hiroshi Okumura
Hiroshi Kurahara
Yasuto Uchikado
Tetsuro Setoyama
Yoshiaki Kita
Yuko Kijima
Yuka Nishizono
Akihiro Nakajo
Tetsuro Owaki
Shinichi Ueno
Shoji Natsugoe
Journal of Experimental & Clinical Cancer Research, 32
[4] Clinical implications of DLL4 expression in gastric cancer
Ishigami, Sumiya
Arigami, Takaaki
Uenosono, Yoshikazu
Okumura, Hiroshi
Kurahara, Hiroshi
Uchikado, Yasuto
Setoyama, Tetsuro
Kita, Yoshiaki
Kijima, Yuko
Nishizono, Yuka
Nakajo, Akihiro
Owaki, Tetsuro
Ueno, Shinichi
Natsugoe, Shoji
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
[5] High Expression of Survivin Is Prognostic of Shorter Survival but Not Predictive of Adjuvant Gemcitabine Benefit in Patients with Resected Pancreatic Adenocarcinoma
Xie, Hao
Jiang, Wei
Xiao, Shu-Yuan
Liu, Xiuli
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2013, 61 (02) : 148 - 155
[6] The Prediction of DLL4 as a Prognostic Biomarker in Patients with Gastric Cancer Using Anti-DLL4 Nanobody
Afzalipour, Reza
Abbasi-Dokht, Tannaz
Sheikh, Maryam
Mohammadlou, Maryam
Nili, Fatemeh
Baharlou, Rasoul
JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (03) : 1380 - 1387
[7] NOTCH AND DLL4 EXPRESSION IN COLON CANCER PATIENTS TREATED WITH BEVACIZUMAB
Negri, Francesca V.
Bozzetti, Cecilia
Lagrasta, Costanza
Crafa, Pellegrino
Cavalli, Stefano
Pedrazzi, Giuseppe
Porzio, Rosa
Bacchini, Gianpaolo
Cavanna, Luigi
Paties, Carlo
Ardizzoni, Andrea
ANNALS OF ONCOLOGY, 2012, 23 : 107 - 108
[8] High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
R Maréchal
P Demetter
N Nagy
A Berton
C Decaestecker
M Polus
J Closset
J Devière
I Salmon
J-L Van Laethem
British Journal of Cancer, 2009, 100 : 1444 - 1451
[9] High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
Marechal, R.
Demetter, P.
Nagy, N.
Berton, A.
Decaestecker, C.
Polus, M.
Closset, J.
Deviere, J.
Salmon, I.
Van Laethem, J-L
BRITISH JOURNAL OF CANCER, 2009, 100 (09) : 1444 - 1451
[10] Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer
Wang, Lin
Cao, Ge
Li, Wei
Chen, Xiao-Wen
Xiong, Shi-Shuang
Mu, Ya-Nan
Jiang, Jin-Fang
Yang, Lan
Zhang, De-Rui
Cao, Yu-Wen
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22

← 1 2 3 4 5 →